Showing 2971-2980 of 10215 results for "".
Dupilumab For the Management of Pembrolizumab-induced Rash: A Case Report
https://practicaldermatology.com/youngmd-connect/resident-resource-center/dupilumab-for-the-management-of-pembrolizumab-induced-rash-a-case-report/23841/New Directions in Acne Care
https://practicaldermatology.com/topics/acne-rosacea/new-directions-in-acne-care/23515/Recent developments and therapeutic advancements continue to improve outcomes in the management of this common, inflammatory disease.News
https://practicaldermatology.com/topics/general-topics/news/21339/Biologic Therapies for 2013: Do We Use Them Enough?
https://practicaldermatology.com/topics/psoriasis/biologic-therapies-for-2013-do-we-use-them-enough/22931/News
https://practicaldermatology.com/topics/general-topics/news/21253/The Most Important Element of Your Financial Plan, Part II
https://practicaldermatology.com/topics/practice-management/the-most-important-element-of-your-financial-plan-part-ii/21313/Why flexibility is crucial to meeting long-term goals.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-39/23790/Acne Management Today: Exploring the Role of Topical Adapalene in OTC Care
https://practicaldermatology.com/topics/acne-rosacea/acne-management-today-exploring-the-role-of-topical-adapalene-in-otc-care/23205/La Roche-Posay’s EFFACLAR Adapalene 0.1% Gel provides effective OTC care for acne.Reassessing Topical 5-Fluorouracil for AK Management
https://practicaldermatology.com/topics/practice-management/reassessing-topical-5-fluorouracil-for-ak-management/21021/New research highlights the beneficial role of this therapeutic mainstay, alone and in combination with lesion-directed treatment.Point/Counterpoint: Is There a Role for Permanent Fillers?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/pointcounterpoint-is-there-a-role-for-permanent-fillers/20916/